전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Schueffler A, Anke T. 2014. Fungal natural products in research and development. Nat. Prod. Rep. 31: 1425-1448.
    Pubmed CrossRef
  2. Blackwell M. 2011. The fungi: 1, 2, 3 .. 5.1 million species? Am. J. Bot. 98: 426-438.
    Pubmed CrossRef
  3. Robey MT, Caesar LK, Drott MT, Keller NP, Kelleher NL. 2021. An interpreted atlas of biosynthetic gene clusters from 1,000 fungal genomes. Proc. Natl. Acad. Sci. USA 118(19): e2020230118.
    Pubmed PMC CrossRef
  4. Monciardini P, Iorio M, Maffioli S, Sosio M, Donadio S. 2014. Discovering new bioactive molecules from microbial sources. Microb. Biotechnol. 7: 209-220.
    Pubmed PMC CrossRef
  5. Hautbergue T, Jamin EL, Debrauwer L, Puel O, Oswald IP. 2018. From genomics to metabolomics, moving toward an integrated strategy for the discovery of fungal secondary metabolites. Nat. Prod. Rep. 35: 147-173.
    Pubmed CrossRef
  6. Scherlach K, Hertweck C. 2009. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 7: 1753-1760.
    Pubmed CrossRef
  7. Netzker T, Fischer J, Weber J, Mattern DJ, Konig CC, Valiante V, et al. 2015. Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters. Front. Microbiol. 6: 299.
    Pubmed PMC CrossRef
  8. Keller NP. 2019. Fungal secondary metabolism: regulation, function and drug discovery. Nat. Rev. Microbiol. 17: 167-180.
    Pubmed PMC CrossRef
  9. Bertrand S, Bohni N, Schnee S, Schumpp O, Gindro K, Wolfender JL. 2014. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Biotechnol. Adv. 32: 1180-1204.
    Pubmed CrossRef
  10. Arora D, Gupta P, Jaglan S, Roullier C, Grovel O, Bertrand S. 2020. Expanding the chemical diversity through microorganisms coculture: Current status and outlook. Biotechnol. Adv. 40: 107521.
    Pubmed CrossRef
  11. Williams RB, Henrikson JC, Hoover AR, Lee AE, Cichewicz RH. 2008. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 6: 1895-1897.
    Pubmed CrossRef
  12. Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. 2013. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat. Prod. Rep. 30: 605-624.
    Pubmed CrossRef
  13. Son S, Ko SK, Jang M, Lee JK, Ryoo IJ, Lee JS, et al. 2015. Ulleungamides A and B, modified alpha,beta-dehydropipecolic acid containing cyclic depsipeptides from Streptomyces sp. KCB13F003. Org. Lett. 17: 4046-4049.
    Pubmed CrossRef
  14. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, et al. 1999. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
    Pubmed CrossRef
  15. Zutz C, Gacek A, Sulyok M, Wagner M, Strauss J, Rychli K. 2013. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. Toxins (Basel) 5: 1723-1741.
    Pubmed PMC CrossRef
  16. Ohsumi K, Masaki T, Takase S, Watanabe M, Fujie A. 2014. AS2077715: a novel antifungal antibiotic produced by Capnodium sp. 339855. J. Antibiot. (Tokyo) 67: 707-711.
    Pubmed CrossRef
  17. Yu NH, Park SY, Kim JA, Park CH, Jeong MH, Oh SO, et al. 2018. Endophytic and endolichenic fungal diversity in maritime Antarctica based on cultured material and their evolutionary position among Dikarya. Fungal Syst. Evol. 2: 263-272.
    Pubmed PMC CrossRef
  18. Kawamoto K, Yamazaki H, Ohte S, Masuma R, Uchida R, Tomoda H. 2011. Production of monapinones by fermentation of the dinapinone-producing fungus Penicillium pinophilum FKI-3864 in a seawater-containing medium. J. Antibiot. (Tokyo) 64: 503-508.
    Pubmed CrossRef
  19. Ohte S, Matsuda D, Uchida R, Nonaka K, Masuma R, Omura S, et al. 2011. Dinapinones, novel inhibitors of triacylglycerol synthesis in mammalian cells, produced by Penicillium pinophilum FKI-3864. J. Antibiot. (Tokyo) 64: 489-494.
    Pubmed CrossRef
  20. Uchida R, Ohte S, Kawamoto K, Yamazaki H, Kawaguchi M, Tomoda H. 2012. Structures and absolute stereochemistry of dinapinones A1 and A2, inhibitors of triacylglycerol synthesis, produced by penicillium pinophilum FKI-3864. J. Antibiot. (Tokyo) 65: 419-425.
    Pubmed CrossRef
  21. Kawaguchi M, Uchida R, Ohte S, Miyachi N, Kobayashi K, Sato N, et al. 2013. New dinapinone derivatives, potent inhibitors of triacylglycerol synthesis in mammalian cells, produced by Talaromyces pinophilus FKI-3864. J. Antibiot. (Tokyo) 66: 179-189.
    Pubmed CrossRef
  22. Kim J, Lee Y, Yu S. 1995. Sambutoxin-producing isolates of fusarium species and occurrence of sambutoxin in rotten potato tubers. Appl. Environ. Microbiol. 61: 3750-3751.
    Pubmed PMC CrossRef
  23. Jayasinghe L, Abbas HK, Jacob MR, Herath WH, Nanayakkara NP. 2006. N-Methyl-4-hydroxy-2-pyridinone analogues from Fusarium oxysporum. J. Nat. Prod. 69: 439-442.
    Pubmed PMC CrossRef
  24. Schmidt Y, Breit B. 2010. Direct assignment of the relative configuration in 1,3,n-methyl-branched carbon chains by 1H NMR spectroscopy. Org. Lett. 12: 2218-2221.
    Pubmed CrossRef
  25. Gupta GP, Massague J. 2006. Cancer metastasis: building a framework. Cell 127: 679-695.
    Pubmed CrossRef
  26. Hoshino S, Onaka H, Abe I. 2019. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria. J. Ind. Microbiol. Biotechnol. 46: 363-374.
    Pubmed CrossRef

Related articles in JMB

More Related Articles

Article

Research article

J. Microbiol. Biotechnol. 2023; 33(11): 1437-1447

Published online November 28, 2023 https://doi.org/10.4014/jmb.2301.01017

Copyright © The Korean Society for Microbiology and Biotechnology.

Induction of Fungal Secondary Metabolites by Co-Culture with Actinomycete Producing HDAC Inhibitor Trichostatins

Gwi Ja Hwang1, Jongtae Roh1,2, Sangkeun Son4, Byeongsan Lee1, Jun-Pil Jang1, Jae-Seoun Hur3, Young-Soo Hong1,2, Jong Seog Ahn1,2, Sung-Kyun Ko1,2*, and Jae-Hyuk Jang1,2*

1Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Republic of Korea
2Department of Biomolecular Science, KRIBB school of Bioscience, University of Science and Technology (UST), Daejeon 34141, Republic of Korea
3Korean Lichen Research Institute, Sunchon National University, Suncheon 57922, Republic of Korea
4Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston 02115 MA, USA

Correspondence to:Jae-Hyuk Jang,        jangjh@kribb.re.kr
Sung-Kyun Ko,        ksk1230@kribb.re.kr

Received: January 12, 2023; Revised: July 5, 2023; Accepted: July 10, 2023

Abstract

A recently bioinformatic analysis of genomic sequences of fungi indicated that fungi are able to produce more secondary metabolites than expected. Despite their potency, many biosynthetic pathways are silent in the absence of specific culture conditions or chemical cues. To access cryptic metabolism, 108 fungal strains isolated from various sites were cultured with or without Streptomyces sp. 13F051 which mainly produces trichostatin analogues, followed by comparison of metabolic profiles using LC-MS. Among the 108 fungal strains, 14 produced secondary metabolites that were not recognized or were scarcely produced in mono-cultivation. Of these two fungal strains, Myrmecridium schulzeri 15F098 and Scleroconidioma sphagnicola 15S058 produced four new compounds (1-4) along with a known compound (5), demonstrating that all four compounds were produced by physical interaction with Streptomyces sp. 13F051. Bioactivity evaluation indicated that compounds 3-5 impede migration of MDA-MB-231 breast cancer cells.

Keywords: Co-culture system, fungal cryptic secondary metabolites, structure determination, physical interaction

Introduction

Fungi are major composers of ecosystems and producer of new secondary metabolites that are used in medicine and agriculture [1]. To date, 100,000 fungi have been identified and approximately 5 million fungal species may exist [2]. A recent whole-genome sequencing analysis indicated that fungi have the potential to produce more secondary metabolites than expected [3]. Despite this genetic capability, many biosynthetic pathways are silent or the rediscovery of secondary metabolites is frequent under traditional laboratory culture conditions [4, 5]. Various strategies have been developed to access cryptic metabolites [6-8]. Co-culture of two microorganisms in the same culture environment is a representative strategy [9, 10]. This strategy induces physical and metabolite interactions between the two microorganisms, which ultimately increases gene expression, and consequently increases metabolite production. Another approach is epigenetic manipulation at the chromatin level using histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors, which regulate transcriptional gene expression in fungi [11, 12].

In a previous study, we examined the chemical profiles of actinomycetes isolated from soil samples collected from Ulleung Island by liquid chromatography-photodiode array-mass spectrometry (LC-PDA-MS) [13]. Among the 208 actinomycete strains isolated, Streptomyces sp. 13F051 produced trichostatin analogues. Trichostatin A (TSA) is a HDAC inhibitor, its mechanism of action has been established; the hydroxamate group of TSA chelates a zinc ion in the active site pocket of HDAC, blocking the catalytic reaction [14]. Owing to its potent HDAC inhibitory activity, TSA has been used to enhance the cryptic secondary metabolites of fungi [15].

We hypothesized that if fungi were cultured with an actinomycete, producing HDAC inhibitors, TSA analogues, novel fungal secondary metabolites are induced by HDAC inhibitors or physical interaction between two microorganisms. To test this hypothesis, various fungal strains were co-cultured with an actinomycete on agar plates, and their metabolic profiles were monitored by LC-MS. The co-culture of Streptomyces sp. 13F051 and the three fungal strains produced secondary metabolites that were not recognized or were scarcely produced in mono-cultures. To determine whether the induced metabolites were produced by HDAC inhibitors or physical interactions, the four fungal strains were cultured with a disk containing acetone extracts of Streptomyces sp. 13F051. The two fungal strains produced the novel secondary metabolites via physical interaction in the co-culture system. Here we report four new fungal secondary metabolites: dinapinone analogues (1 and 2), sambutoxin analogues (3 and 4) and a known compound AS2077715 (5) [16] induced by physical interaction in the co-culture system. After isolation, all the compounds were further studied to elucidate their structure and biological activities.

Materials and Methods

General Experimental Procedures

Optical rotations were measured using a JASCO P-1020 polarimeter (JASCO, Japan). UV spectra were recorded on a NP80 NanoPhotometer (IMPLEN, Germany). Nuclear magnetic resonance (NMR) spectra were obtained in CD3OD:CDCl3 co-solvent as the internal standards (δH 3.31/δC 49.1) and (δH 7.24/δC 77.2), respectively or DMSO-d6 (δH 2.49/δC 39.5) using a Bruker AVANCE HD 700 MHz NMR spectrometer (Bruker, Germany) at the Korea Basic Science Institute (KBSI) in Ochang, Korea. High-resolution electrospray ionisation mass spectrometry (HRESIMS) were recorded on a Waters Synapt G2 mass spectrometer (Waters, USA) at the KBSI in Ochang, Korea. Analytical C18 (Nacalai Tesque, Japan, 5 μm, 4.6 × 150 mm), analytical C30 (Nomura Chemical, Japan, 5 μm, 4.6 × 150 mm) and semipreparative C18 (Nacalai Tesque, Japan; 10 μm, 10 × 250 mm) columns were used for reversed-phase HPLC equipped with a Waters 2996 photodiode array detector (Waters). High-performance liquid chromatography (HPLC) grade solvents (Burdick & Jackson, USA) were used. Liquid chromatography-mass spectrometry (LC-MS) analysis was performed using an LTQ XL linear ion trap (Thermo Scientific, USA) equipped with an electrospray ionization (ESI) source coupled with a rapid separation LC (RSLC; ultimate 3000, Thermo Scientific) system (ESI-LC-MS).

Strain Identification

Soil samples were collected from Ulleung Island, Republic of Korea [13]. Among the isolated strains, 13F051 displayed the most similar 16S rRNA gene sequence (GenBank Accession No. MW774247) to Streptomyces sioyaensis NRRL B-5408 (99%, 1442/1449), Streptomyces inhibens NEAU-D10 (99%, 1442/1449), and Streptomyces auratus NRRL 8097 (99%, 1439/1449). Therefore, strain 13F051 was named Streptomyces sp. 13F051 and was used in subsequent culture experiments.

Fungal strain 15F098 was isolated from soil samples collected from Jeju Island. BLAST similarity search analysis indicated that the internal transcribed spacer (ITS) sequence of the 15F098 fungal strain had the most similar ITS sequence (GenBank Accession No. OL376480) to that of Myrmecridium schulzeri CSB_F134 (99%, 480/485), Myrmecridium schulzeri MS3 (98%, 502/513), and Myrmecridium schulzeri PWQ2293 (98%, 491/499). Therefore, the strain 15F098 was identified as Myrmecridium schulzeri 15F098.

The endolichenic fungal strain 15S058 was provided by the Korea Lichen & Allied Bioresources Center (KOLABIC), Korea Lichen Research Institute (KoLRI), Sunchon National University [17]. This strain had the most similar ITS sequence (GenBank Accession No. OK639166) to that of Scleroconidioma sphagnicola NK08 (99%, 568/569), Scleroconidioma sp. K22W31 (99%, 566/567), and Dothideomycetes sp. JMUR-2016 (99%, 549/550). Therefore, strain 15S058 was identified as Scleroconidioma sphagnicola 15S058 (Institutional code: KoLRI031248).

Fermentation

Streptomyces sp. 13F051 was maintained on a 60-mm petri dish containing soluble starch and yeast extract (SY) agar medium (soluble starch, 10.0 g; yeast extract, 1.0 g; tryptone, 1.0 g; agar, 18.0 g in 1 L of distilled water) at 28°C for 3 days. The two fungal strains were maintained on a 60-mm petri dish in potato dextrose (PD) agar medium (dextrose, 20.0 g; potato extract, 4.0 g; agar, 18.0 g in 1 L of distilled water). The soil derived fungus M. schulzeri 15F098 was cultured at 28°C for 7 days. The endolichenic fungus S. sphagnicola 15S058 was cultured at 25°C for 7 days.

For each co-culture experiment, Streptomyces sp. 13F051 was circularly inoculated with a 10-mm diameter at the center of a 60-mm petri dish using an inoculation loop. Two agar pieces (10 × 10 mm) of each fungal strain were placed on both sides of Streptomyces sp. 13F051. The co-culture dishes containing ISP2 medium (yeast extract, 4.0 g; malt extract, 10.0 g; dextrose, 4.0 g; agar, 20.0 g in 1 L of distilled water) of Streptomyces sp. 13F051 and M. schulzeri 15F098 were incubated at 28°C for 14 days. Streptomyces sp. 13F051 and S. sphagnicola 15S058 were co-incubated on 60-mm petri dish containing Malt extract (MYE) agar medium (malt extract, 6.0 g; maltose, 1.8 g; dextrose, 6.0 g; yeast extract, 1.2 g; agar, 18 g in 1 L of distilled water) at 25°C for 14 days. Scaled-up cultures were followed the same process.

Extraction and Isolation

Each cultured agar media (60-mm dish × 100) was soaked with acetone three times, and acetone was removed from the organic solvent fraction by evaporation. A acetone extracts (Streptomyces sp. 13F051 with M. schulzeri 15F098, 0.8 g; S. sphagnicola 15S058, 1.2 g) were fractionated by ODS chromatography with a stepwise solvent system of MeOH-H2O (from 20:80, 40:60, 60:40, 80:20, to 100:0; 1 L for each step). Fraction 5 from M. schulzeri 15F098 and Streptomyces sp. 13F051 co-culture extracts was purified by reversed-phase HPLC (Nacalai Tesque-semipreparative C18, 50%–85% CH3CN over 40 min, 3 ml/min, UV detection at 270 and 370 nm) to give compounds 1 and 2 (3.3 mg, tR 30.1 min). Compound 1 (2.7 mg, tR 23.8 min) and 2 (0.3 mg, tR 21.5 min) were isolated by reversed-phase HPLC (Nomura chemical-analytic C30, 70% CH3CN over 50 min, 0.8 ml/min). Compounds 3 (0.9 mg, tR 34.5 min), 4 (1.2 mg, tR 44.1 min), and 5 (1.8 mg, tR 15.5 min) produced by co-culture system of S. sphagnicola 15S058 and Streptomyces sp. 13F051 were isolated by reversed-phase HPLC (Nacalai Tesque-semipreparative C18, 55%–80% CH3CN over 50 min, 3 ml/min).

Dinapinone analogue 1 (1). Brown amorphous powder;αD25+205.0 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 222 (3.33), 289 (4.75), 384 (3.68) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 945.4249 [M + Na]+ (calcd for C50H66O16Na, 945.4249).

Table 1 . 1H (700 MHz) and 13C (150 MHz) NMR data of 1 in CD3OD:CDCl3 = 1:1..

Position1Position1
δC, typeδH, mult. (J in Hz)δC, typeδH, mult. (J in Hz)
1172.4, Cb1'172.4, Cb
22'
378.7, CH4.86, m3'78.7, CH4.86, m
433.4, CH23.19, m
3.06, m
4'33.4, CH23.19, m
3.06, m
4a133.8, C4a'133.8, C
5117.3, CH7.05, s5'117.3, CH7.05, s
5a141.0, C5a'141.0, C
699.0, CH6.76, s6'99.0, CH6.76, s
7162.6, C7'162.6, C
8109.0, C8'109.0, C
9155.8, C9'155.8, C
9a109.0, C9a'109.0, C
10163.8, C10'163.8, C
10a100.2, C10a'100.2, C
1156.4, CH33.82, s11'56.4, CH33.82, s
1242.7, CH22.10, m
1.92, m
12'42.7, CH22.10, m
1.92, m
1368.6, CH4.10, ma13'67.8, CH4.10, ma
1444.8, CH21.61, ma14'43.7, CH21.66, ma
1.59, ma
1572.1, CH3.80, m15'70.8, CH4.05, m
1638.6, CH21.44, ma16'44.2, CH21.67, ma
1.59, ma
1726.0, CH21.42, ma
1.30, ma
17'71.3, CH4.03, m
1830.3, CH21.24, ma18'44.3, CH21.59, ma
1.52, m
1930.3, CH21.24, ma19'71.6, CH3.77, m
2032.5, CH21.25, m20'40.7, CH21.42, ma
2123.3, CH21.27, m21'19.2, CH21.41, ma
1.34, ma
2214.4, CH30.86, dd (8.5, 5.3)22'14.4, CH30.90, dd (8.5, 5.3)

aResonances overlapped.

bPeaks only detected in HMBC.



Dinapinone analogue 2 (2). Brown amorphous powder;αD25-188.1 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 222 (3.32), 290 (4.75), 383 (3.66) nm; HRESIMS m/z 923.4433 [M + H]+ (calcd for C50H67O16, 923.4429).

Sambutoxin analogue 1 (3). White amorphous powder;αD25-35.92 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 255 (4.02), 295 (3.69) nm; 1H and 13C NMR data, Table 2; HRESIMS m/z 436.2465 [M + Na]+ (calcd for C29H34N4O6Na, 436.2464).

Table 2 . 1H (700 MHz) and 13C (150 MHz) NMR data of 3 and 4 in DMSO-d6..

Position34
δC, typeδH, mult. (J in Hz)δC, typeδH, mult. (J in Hz)
111.2, br
2160.9, C160.1, C
3109.5, C108.9, C
4161.8, C160.6, Cb
5113.1, C112.8, C
6132.3, CH7.11, s137.0, C7.55, s
776.7, CH4.76, dd (11.2, 1.5)77.1, CH4.80, dd, (11.1, 1.5)
829.8, CH21.82, ma
1.41, ma
29.7, CH21.82, ma
1.39, m
922.7, CH21.82, ma
1.59, m
22.7, CH21.81, ma
1.59, m
1030.6, CH21.65, m
1.30, ma
30.6, CH21.65, m
1.30, ma
1179.2, CH3.50, m79.2, CH3.49, m
1233.1, CH21.49, m33.1, CH21.50, m
1332.8, CH21.34, m
1.10, m
32.8, CH21.34, ma
1.10, ma
1429.6, CH1.43, m29.6, CH1.43, m
1543.7, CH21.03, t (7.0)43.6, CH21.03, t (7.0)
1631.1, CH1.35, ma31.1, CH1.35, ma
1729.7, CH21.25, ma
1.09, m
29.7, CH21.25, ma
1.09, ma
1811.2, CH30.81, t (7.4)11.2, CH30.81, t (7.4)
1-N-methyl36.1, CH33.38, s
14-methyl19.4, CH30.80, d (6.5)19.4, CH30.80, d (6.5)
16-methyl18.8, CH30.78, d (6.5)18.8, CH30.78, d (6.5)
1'124.7, C124.5, C
2'130.0, CH7.19, d (8.4)130.0, CH7.21, d (8.5)
3'114.8, CH6.73, d (8.4)114.8, CH6.75, d (8.5)
4'156.4, C156.4, C
5'114.8, CH6.73, d (8.4)114.8, CH6.75, d (8.5)
6'130.0, CH7.19, d (8.4)130.0, CH7.21, d (8.5)

aResonances overlapped.

bPeaks only detected in HMBC NMR.



Sambutoxin analogue 2 (4). White amorphous powder;αD25-73.64 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 255 (4.12), 295 (3.69) nm; 1H and 13C NMR data, Table 2; HRESIMS m/z 450.2620 [M + Na]+ (calcd for C29H34N4O6Na, 450.2620).

Induction Mechanism Monitoring Assay

Streptomyces sp. 13F051 was cultured following the same culture process as for co-culture with each fungal strain. The cultured agar media were soaked in acetone three times and evaporated to remove the solvent. M. schulzeri 15F098 was cultured on ISP2 agar media with a paper disk containing the acetone extracts of Streptomyces sp. 13F051 (0.5 mg/disk). S. sphagnicola 15S058 was cultured with acetone extracts (0.5 mg/disk) of Streptomyces sp. 13F051 on MYE agar media. Streptomyces sp. KCB13F003 was cultured with two fungal strains and monitored using the same process.

Antibacterial Assay

Two gram-positive bacteria (Enterococcus faecalis KCTC 5191 and Bacillus subtilis KCTC 1021) and two gram-negative bacteria (Escherichia coli CCARM 1356 and Pseudomonas aeruginosa KCTC 2004) were cultured using Mueller-Hinton broth (5 ml/15 ml tube) at 28°C for 24 h. Then, 20 μl of 1 × 105 CFU/ml was inoculated on Brain Heart Infusion (HBI) agar plates (90-mm), followed by loading the disks, which contained 50 μg of mixture (1 and 2) and 3-5. After incubation at 28°C for 72 h, antibacterial activity was evaluated by measuring the diameter of the growth inhibition zone.

Cell Viability Assay

HeLa (human cervical cancer), MDA-MB-231 (human breast cancer), Neuro-2a (mouse neuroblastoma), and PC12 (pheochromocytoma of rat adrenal medulla) cell lines were maintained in Dulbeccós modified Eaglés medium (LM 001-05, DMEM, Welgene, Korea) containing 10% fetal bovine serum (FBS; Welgene, Korea, S 001-07), 100 units penicillin, and 100 μg/ml streptomycin (15140-122, Gibico, USA) at 37°C with 5% CO2 in a humidified atmosphere. Each cell line was seeded into 96-well cell culture plates (1 × 104 cells/well) and incubated for 16 h. The cells were then treated with various concentrations of the test compounds. After incubation for 24 h, 10 μl of EZ-Cytox colorimetric assay (0793, Daeil Lab service, Korea) was directly added and incubated at 37°C for 2 h. Absorbance was measured at 450 nm using a microplate reader (Spectra Max 190, Molecular Devices, USA). Cell viability was normalized to that of control cells.

Scratch Wound Healing Assay

MDA-MB-231 cells were seeded overnight in 24-well cell culture plates (8 × 104 cells/well). Each well was artificially scratched using a Scar scratcher (201925, SPL, Korea). The cells were incubated in DMEM containing 1 μg/ml mitomycin C for 3 h, followed by incubation with the test compounds at the indicated concentrations. After incubation for 24 h, the cells were fixed in 4% paraformaldehyde for 15 min, stained with 0.2% crystal violet, and imaged under a microscope. Wound closure areas were measured using ImageJ (Software 1.48q, Rayne Rasband, National Institutes of Health, USA)

Time-lapse Cell Tracking Analysis.

MDA-MB-231 cells (8 × 103 cells/100 μl) were seeded on μ-Slide I (80106, ibidi, Germany). After 4 h, 900 μl DMEM was added to the slide. After incubation for 16 h, cells were treated with indicated concentrations of compound and directly transferred to a HoloMonitor M4 time-lapse cytometer (Phase Holographic Imaging) kept in a 37°C incubator. Live cells were imaged every 15 min for 12 h. Migration was analyzed using the HoloStudio M4 software.

Results

Strain Selection using the Co-Culture System

A total of 108 fungal strains were co-cultured with Streptomyces sp. 13F051 producing the HDAC inhibitor trichostains, on agar media for 14 days, with the goal of increasing the production of cryptic metabolites. The metabolic profiles of mono- and co-cultured fungi were monitored by LC-MS to detect newly enhanced peaks in the co-culture system. The 14 fungal strains were selected as the candidates to produce the secondary metabolites that were not recognized or scarcely produced in mono-cultures. Finally, three fungal strains that produced novel secondary metabolites were selected for further studies based on searches of public and in-house databases with UV and MS data.

To identify the producer of the induced compounds, we monitored the chemical profiles of each mono-cultured extracts by LC-MS. The fungal strains produced the induced compounds, which was also confirmed by previous studies and are discussed below.

Induction Factors for Fungal Derived Compounds (1−5) in Co-Culture System

When designing a co-culture experiment, physical interactions or the small molecules produced by the microorganism are speculated to increase the amount of secondary metabolites produced in the co-culture system. To investigate the induction factors that enhanced the production of compounds in the co-culture, each of the three fungal strains was cultured with a disk containing acetone extracts of Streptomyces sp. 13F051 (0.5 mg) and analyzed by LC-MS. Except for one fungal strain (data not shown), compounds 1 and 2 that were induced in the co-culture of M. schulzeri 15F098 with Streptomyces sp. 13F051 and compounds 3-5 that were induced in the co-culture of S. sphagnicola 15S058 with Streptomyces sp. 13F051, were not detected in the culture system with acetone extracts of Streptomyces sp. 13F051, suggesting that these metabolites were induced by physical contacts with Streptomyces sp. 13F051 (Figs. 1, S1, and S3). Each of the two fungal strains was cultured with Streptomyces sp. KCB13F003 that does not produce trichostatins. The chemical profiles of each co-cultured extract were compared using LC-MS; compounds 1-5 were not observed in the co-culture system with Streptomyces sp. KCB13F003 (Figs. S2 and S4). However, because compounds 1-5 were not detected in the strain that does not produce trichostatins, it was concluded that these compounds were formed only by co-culture with Streptomyces sp. 13F051. Therefore, four compounds (1-5) induced by physical interaction with Streptomyces sp. 13F051 were further studied.

Figure 1. Chemical structures of isolated compounds 1‒5 in the co-culture system.

Structure Determination

Mixture of compounds 1 and 2 was isolated as a brown amorphous powder. Based on NMR spectroscopy analysis, the planar structure of mixture was assumed to be dinapinone analogues isolated from Talaromyces pinophilus FKI-3864 [18-21]. Therefore, it was proposed that compounds produced by fungal strain M. schulzeri 15F098. A previous studies have reported that dinapinone analogues are atropisomers, and are separated by ODS C30 column [18-21]. Compounds 1 and 2 were obtained by further purification using ODS C30 column and confirmed using HRESIMS analysis and NMR spectroscopy analysis (Table 1). Molecular formulas of 1 and 2 were determined to be C50H66O16 with 18 unsaturated degrees. Similar to dinapinone derivatives, 1 was composed of two partial structures corresponding to 9,10-dihydroxy-7-methoxy-3-hydro-benzoisochromene-1-one and a linear hydroxylated alkyl chain. Based on the HMBC correlations between H/C-4 (δH/C 3.17 and 3.08/33.5) and H/C-12 (δH/C 2.19 and 2.02/42.5), the connection between dihydronaphthopyranone and the dihydroxylalkyl chain of partial structure I was determined as shown in Fig. 2 Additional HMBC correlations between H/C-4' (δH/C 3.17 and 3.08/33.5) and H/C-12' (δH/C 2.19 and 2.02/42.5) indicated that partial structure II consisted of dihydronaphthopyranone and tetrahydroxylalkyl chain. Furthermore, the connection pattern of the two partial structures was determined by the carbon chemical shifts of quaternary C-8 and C-8' (δC 109.5) (Fig. 2). The most similar structure of 1 was identified as dinapinone AC in previous study [21], which was not detected in co-culture system with M. schulzeri 15F098. The difference between the planar structure of 1 and dinapione AC is the long branched carbon chains with a propionate unit on both sides (C-12-C-22 and C-12'-C-22') instead of the short carbon chains (C-12-C-20 and C-12'-C-20') (Fig. 4). Among the dinapinone analogues, compound 1 had the longest branched carbon chain.

Figure 2. Selected COSY and HMBC correlations.
Figure 4. Structurally related known compounds, Dianapinone AC2 and Sambutoxin.

The relative configurations of the hydroxylated C-3, C-13, and C-15 corresponding to carbon chains were established as 3S*, 13R*, and 15R* based on ROESY correlations (Fig. 3), and C-3', C-13', C-15', C-17', and C-19' had 3'S*, 13'R*, 15'R*, 17'R*, and 19'R* configuration, indicating that 1 had the same relative configuration as dinapione AC. Acetonide derivatizaion of the secondary alcohols in 1 did not yield sufficient amounts to confirm the relative configurations, presumably due to the presence of numerous secondary alcohols in 1. According to previous reports, the CD data of dinapione analogues were compared with those of (S)-, (R)-vioxanthin, dihydronaphthopyranone to determine the absolute axis configuration. The M-axis configured substances exhibit negative specific rotation values, whereas P-axis compounds have positive specific rotation values [20, 21]. The specific rotation value of 1 was positive. Considering that 1 has structure similar to that of dinapione AC and has a positive value of specific rotation, the absolute axis configuration of 1 was determined as P.

Figure 3. Key ROESY correlations and coupling constants.

While, NMR spectra of compound 2 were not obtained due to insufficient amount, compound 2 was determined as atropisomer of compound 1 based on HRESIMS spectroscopy. In addition, since 2 has negative specific rotation values, the absolute axis configuration of 2 was determined to be M.

Compound 3 was isolated as a white amorphous powder. The molecular formula of 2 was determined to be C25H35NO4 with nine unsaturation degrees based on HRESIMS and NMR spectroscopy (Table 2). The NMR spectra of 3 suggested that 3 is a sambutoxin analogue, which was first isolated from the potato parasite Fusarium sambucinum[22]. Sambutoxin was also detected in co-culture system with S. sphagnicola 15S058, but NMR spectra were not obtained owing to insufficient amounts. Comparison of the 1H and 13C NMR spectra of 3 and sambutoxin indicated that olefin signals corresponding to the chain of sambutoxin were not detected in the spectra of 3. Instead, two new signals were identified at δH/C 1.49/33.1 and δH/C 1.34 and 1.10/32.8, which were attributed to methylene. Furthermore, the three methyl signals substituted at N-1, C-10, and C-12 of sambutoxin were disappeared. Instead, NH signal was detected at δH 11.2 and two new methylene signals were detected at δH/C 1.65 and 1.30/30.6 and δH/C 1.49/33.1 corresponding to tetrahydronpyran and chain of 3. Compound 3 is a sambutoxin analogue with demethylated tetrahydropyran and saturated carbon chain (Fig. 4). The planar structure of 3 was confirmed by 1H-1H correlation spectroscopy (COSY) and heteronuclear multiple bond correlation (HMBC) spectroscopy (Fig. 2).

The relative configuration of the tetrahydropyran moiety was determined using coupling constant and ROESY correlations (Fig. 3). The coupling constant between H-7 and H-8ax was relatively large (3J = 11.2), indicating that the protons were located in axial position. Furthermore, the position of H-11 was established as axial by the rotating-frame nuclear Overhauser effect spectroscopy (ROESY) correlation between H-11 and H-7ax and H-10eq. The relative configuration of the 1,3-dimethyl-barnched carbon chain was determined based on the 1H NMR chemical shift difference (Δδ) of its germinal methylene protons, H-15 (Fig. 3). The anti-configured substances have Δδ values of 0.0-0.2 ppm, while syn-compounds have Δδ values of 0.2-0.5 ppm [24]. The Δδ value between the germinal methylene protons (H-15) of 3 was relatively small, indicating that the two methyl groups of the 1,3-dimethyl-barnched carbon chain of 3 were in an anti-configuration.

Compound 4 was isolated as a white amorphous powder. The spectroscopic features of 4 were similar to those of 3. However, its molecular formula was determined to be C26H37NO4 by HRESIMS, indicating the presence of a methyl group. The chemical composition of 4 was further confirmed by 1H and 13C NMR spectra, where an N-methyl signal was detected at δH/C 3.38/36.1, suggesting that the methyl group was substituted at the pyridone moiety. Based on COSY and HMBC correlations, the planar structure of 4 was identified as a demethyl sambutoxin analogue with a saturated carbon chain (Fig. 2) [23].

The relative configurations at C-7, C-11, C-14, and C-16 were determined based on the Δδ values of its germinal methylene protons (H-15) and ROESY correlation, similar to 3 as shown in Fig. 3 [23].

Biological Activities

Few microbial chemical cues promote the activation of silent biosynthetic gene clusters encoding defensive secondary metabolites to enhance survival in co-cultures of bacteria and fungi [10]. Based on the observation that the quantities of compounds 1 and 2 (mixture = 9:1, before separation of atropisomers) and 3-5 were enhanced by co-culture with actinomycete, it was assumed that 1 and 2 (mixture) and 3-5 have antibacterial activity. To test this hypothesis, an agar disk diffusion assay was performed to evaluate the antibacterial activity of 1 and 2 (mixture) and 3-5 against various pathogenic bacteria. However, compounds 1 and 2 (mixture) and 3-5 were inactive (Table S1). Compounds 1 and 2 (mixture) and 3-5 were not cytotoxic in various cancer cell lines (Table S2). Only 5 was cytotoxic against PC12 cells at a concentration of up to 50 μM. Cell migration is implicated in cancer cell metastasis [25]. To evaluate anti-migration activity, we performed a scratch wound healing assay in MDA-MB-231 cells. After treatment with the indicated concentrations of the test compounds for 24 h, the rate of cells migrating to the empty area was significantly decreased by treatment with compounds 3, 4, and 5 in a dose-dependent manner (Fig. 5). To further investigate the effect of the compounds on cell migration, we performed time-lapse cell tracking analysis. The cells were treated with 25 μM of the indicated compounds. Cell movement was captured with a HoloMonitor M4 time-lapse cytometer every 15 min for 12 h. As expected, cell motility was markedly inhibited in cells treated with compounds 3 (44% inhibition), 4 (32% inhibition), and 5 (65% inhibition) compared to control cells treated with DMSO (Fig. 6).

Figure 5. Effects of compounds on the migration of MDA-MB-231 cells. (A) Representative images of wound-healing assay. (B) Quantitative wound healing data obtained by measuring the wound area.
Figure 6. Effects of compounds on cell mobility of MDA-MB-231 cells. (A) Cells were treated with 25 μM of each compound. Cell movement was captured every 15 min for 12 h. (B) Cell mobility analyzed with HoloStudio M4 software.

Discussion

This co-culture system, four new and one known compounds were isolated from the co-culture of two fungal strains with Streptomyces sp. 13F051. Based on comprehensive LC-MS analyses of chemical profiles and literature data, the four new compounds (1-4) originated from two fungal strains (M. schulzeri 15F098, and S. sphagnicola 15S058).

When the co-culture experiment was designed, the fungal secondary metabolites were expected to be produced by HDAC inhibitors produced by Streptomyces sp. 13F051 or by the interaction of physical contacts or chemicals other than trichostatins. Based on the disk diffusion assay with acetone extracts of Streptomyces sp. 13F051, it was found that compounds 1-5 were produced by physical interaction with Streptomyces sp. 13F051. The co-culture system led to complex microbial communities based on chemical-ecological interactions. Therefore, defining induction mechanisms is a challenging task. Only a few studies have described the induction mechanisms of secondary metabolites in co-culture system. Some studies have proposed that secondary metabolites are induced by the microbial defense system against the counterpart microorganism [10]. Only few examples have used microorganisms that produced enhancers of secondary metabolites, such as antibiotics, volatile organic compounds, quorum sensing molecules and mycolic acid [26]. However, there has been no reference to the use of microorganisms that produce HDAC inhibitors in co-culture systems. Although fungal derived compounds 1-5 were not produced by trichostatins, co-culture with a HDAC inhibitor producer is proposed as one of the strategies for inducing fungal secondary metabolites. Further broad-range co-culture experiments with fungal strains are require to confirm the effectiveness of this designed method.

The new compounds (1-4) structurally related to dinapione and sambutoxin. Although their structural novelty is not notable, the discovery of these compounds increases the structural diversity of available analogues and extends their biological activities.

Supplemental Materials

Acknowledgments

This work was supported by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (KGM52922322 and KGM1222312) funded by the Ministry of Science ICT (MSIT) and the Basic Science Research Program (2021R1I1A2049704) of the Ministry of Education of the Republic of Korea. We thank the Korea Basic Science Institute, Ochang, Korea, for providing the NMR (700MHz) and HRESIMS data.

Conflict of Interest

The authors have no financial conflicts of interest to declare.

Fig 1.

Figure 1.Chemical structures of isolated compounds 1‒5 in the co-culture system.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Fig 2.

Figure 2.Selected COSY and HMBC correlations.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Fig 3.

Figure 3.Key ROESY correlations and coupling constants.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Fig 4.

Figure 4.Structurally related known compounds, Dianapinone AC2 and Sambutoxin.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Fig 5.

Figure 5.Effects of compounds on the migration of MDA-MB-231 cells. (A) Representative images of wound-healing assay. (B) Quantitative wound healing data obtained by measuring the wound area.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Fig 6.

Figure 6.Effects of compounds on cell mobility of MDA-MB-231 cells. (A) Cells were treated with 25 μM of each compound. Cell movement was captured every 15 min for 12 h. (B) Cell mobility analyzed with HoloStudio M4 software.
Journal of Microbiology and Biotechnology 2023; 33: 1437-1447https://doi.org/10.4014/jmb.2301.01017

Table 1 . 1H (700 MHz) and 13C (150 MHz) NMR data of 1 in CD3OD:CDCl3 = 1:1..

Position1Position1
δC, typeδH, mult. (J in Hz)δC, typeδH, mult. (J in Hz)
1172.4, Cb1'172.4, Cb
22'
378.7, CH4.86, m3'78.7, CH4.86, m
433.4, CH23.19, m
3.06, m
4'33.4, CH23.19, m
3.06, m
4a133.8, C4a'133.8, C
5117.3, CH7.05, s5'117.3, CH7.05, s
5a141.0, C5a'141.0, C
699.0, CH6.76, s6'99.0, CH6.76, s
7162.6, C7'162.6, C
8109.0, C8'109.0, C
9155.8, C9'155.8, C
9a109.0, C9a'109.0, C
10163.8, C10'163.8, C
10a100.2, C10a'100.2, C
1156.4, CH33.82, s11'56.4, CH33.82, s
1242.7, CH22.10, m
1.92, m
12'42.7, CH22.10, m
1.92, m
1368.6, CH4.10, ma13'67.8, CH4.10, ma
1444.8, CH21.61, ma14'43.7, CH21.66, ma
1.59, ma
1572.1, CH3.80, m15'70.8, CH4.05, m
1638.6, CH21.44, ma16'44.2, CH21.67, ma
1.59, ma
1726.0, CH21.42, ma
1.30, ma
17'71.3, CH4.03, m
1830.3, CH21.24, ma18'44.3, CH21.59, ma
1.52, m
1930.3, CH21.24, ma19'71.6, CH3.77, m
2032.5, CH21.25, m20'40.7, CH21.42, ma
2123.3, CH21.27, m21'19.2, CH21.41, ma
1.34, ma
2214.4, CH30.86, dd (8.5, 5.3)22'14.4, CH30.90, dd (8.5, 5.3)

aResonances overlapped.

bPeaks only detected in HMBC.


Table 2 . 1H (700 MHz) and 13C (150 MHz) NMR data of 3 and 4 in DMSO-d6..

Position34
δC, typeδH, mult. (J in Hz)δC, typeδH, mult. (J in Hz)
111.2, br
2160.9, C160.1, C
3109.5, C108.9, C
4161.8, C160.6, Cb
5113.1, C112.8, C
6132.3, CH7.11, s137.0, C7.55, s
776.7, CH4.76, dd (11.2, 1.5)77.1, CH4.80, dd, (11.1, 1.5)
829.8, CH21.82, ma
1.41, ma
29.7, CH21.82, ma
1.39, m
922.7, CH21.82, ma
1.59, m
22.7, CH21.81, ma
1.59, m
1030.6, CH21.65, m
1.30, ma
30.6, CH21.65, m
1.30, ma
1179.2, CH3.50, m79.2, CH3.49, m
1233.1, CH21.49, m33.1, CH21.50, m
1332.8, CH21.34, m
1.10, m
32.8, CH21.34, ma
1.10, ma
1429.6, CH1.43, m29.6, CH1.43, m
1543.7, CH21.03, t (7.0)43.6, CH21.03, t (7.0)
1631.1, CH1.35, ma31.1, CH1.35, ma
1729.7, CH21.25, ma
1.09, m
29.7, CH21.25, ma
1.09, ma
1811.2, CH30.81, t (7.4)11.2, CH30.81, t (7.4)
1-N-methyl36.1, CH33.38, s
14-methyl19.4, CH30.80, d (6.5)19.4, CH30.80, d (6.5)
16-methyl18.8, CH30.78, d (6.5)18.8, CH30.78, d (6.5)
1'124.7, C124.5, C
2'130.0, CH7.19, d (8.4)130.0, CH7.21, d (8.5)
3'114.8, CH6.73, d (8.4)114.8, CH6.75, d (8.5)
4'156.4, C156.4, C
5'114.8, CH6.73, d (8.4)114.8, CH6.75, d (8.5)
6'130.0, CH7.19, d (8.4)130.0, CH7.21, d (8.5)

aResonances overlapped.

bPeaks only detected in HMBC NMR.


References

  1. Schueffler A, Anke T. 2014. Fungal natural products in research and development. Nat. Prod. Rep. 31: 1425-1448.
    Pubmed CrossRef
  2. Blackwell M. 2011. The fungi: 1, 2, 3 .. 5.1 million species? Am. J. Bot. 98: 426-438.
    Pubmed CrossRef
  3. Robey MT, Caesar LK, Drott MT, Keller NP, Kelleher NL. 2021. An interpreted atlas of biosynthetic gene clusters from 1,000 fungal genomes. Proc. Natl. Acad. Sci. USA 118(19): e2020230118.
    Pubmed KoreaMed CrossRef
  4. Monciardini P, Iorio M, Maffioli S, Sosio M, Donadio S. 2014. Discovering new bioactive molecules from microbial sources. Microb. Biotechnol. 7: 209-220.
    Pubmed KoreaMed CrossRef
  5. Hautbergue T, Jamin EL, Debrauwer L, Puel O, Oswald IP. 2018. From genomics to metabolomics, moving toward an integrated strategy for the discovery of fungal secondary metabolites. Nat. Prod. Rep. 35: 147-173.
    Pubmed CrossRef
  6. Scherlach K, Hertweck C. 2009. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 7: 1753-1760.
    Pubmed CrossRef
  7. Netzker T, Fischer J, Weber J, Mattern DJ, Konig CC, Valiante V, et al. 2015. Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters. Front. Microbiol. 6: 299.
    Pubmed KoreaMed CrossRef
  8. Keller NP. 2019. Fungal secondary metabolism: regulation, function and drug discovery. Nat. Rev. Microbiol. 17: 167-180.
    Pubmed KoreaMed CrossRef
  9. Bertrand S, Bohni N, Schnee S, Schumpp O, Gindro K, Wolfender JL. 2014. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Biotechnol. Adv. 32: 1180-1204.
    Pubmed CrossRef
  10. Arora D, Gupta P, Jaglan S, Roullier C, Grovel O, Bertrand S. 2020. Expanding the chemical diversity through microorganisms coculture: Current status and outlook. Biotechnol. Adv. 40: 107521.
    Pubmed CrossRef
  11. Williams RB, Henrikson JC, Hoover AR, Lee AE, Cichewicz RH. 2008. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 6: 1895-1897.
    Pubmed CrossRef
  12. Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. 2013. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat. Prod. Rep. 30: 605-624.
    Pubmed CrossRef
  13. Son S, Ko SK, Jang M, Lee JK, Ryoo IJ, Lee JS, et al. 2015. Ulleungamides A and B, modified alpha,beta-dehydropipecolic acid containing cyclic depsipeptides from Streptomyces sp. KCB13F003. Org. Lett. 17: 4046-4049.
    Pubmed CrossRef
  14. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, et al. 1999. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
    Pubmed CrossRef
  15. Zutz C, Gacek A, Sulyok M, Wagner M, Strauss J, Rychli K. 2013. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. Toxins (Basel) 5: 1723-1741.
    Pubmed KoreaMed CrossRef
  16. Ohsumi K, Masaki T, Takase S, Watanabe M, Fujie A. 2014. AS2077715: a novel antifungal antibiotic produced by Capnodium sp. 339855. J. Antibiot. (Tokyo) 67: 707-711.
    Pubmed CrossRef
  17. Yu NH, Park SY, Kim JA, Park CH, Jeong MH, Oh SO, et al. 2018. Endophytic and endolichenic fungal diversity in maritime Antarctica based on cultured material and their evolutionary position among Dikarya. Fungal Syst. Evol. 2: 263-272.
    Pubmed KoreaMed CrossRef
  18. Kawamoto K, Yamazaki H, Ohte S, Masuma R, Uchida R, Tomoda H. 2011. Production of monapinones by fermentation of the dinapinone-producing fungus Penicillium pinophilum FKI-3864 in a seawater-containing medium. J. Antibiot. (Tokyo) 64: 503-508.
    Pubmed CrossRef
  19. Ohte S, Matsuda D, Uchida R, Nonaka K, Masuma R, Omura S, et al. 2011. Dinapinones, novel inhibitors of triacylglycerol synthesis in mammalian cells, produced by Penicillium pinophilum FKI-3864. J. Antibiot. (Tokyo) 64: 489-494.
    Pubmed CrossRef
  20. Uchida R, Ohte S, Kawamoto K, Yamazaki H, Kawaguchi M, Tomoda H. 2012. Structures and absolute stereochemistry of dinapinones A1 and A2, inhibitors of triacylglycerol synthesis, produced by penicillium pinophilum FKI-3864. J. Antibiot. (Tokyo) 65: 419-425.
    Pubmed CrossRef
  21. Kawaguchi M, Uchida R, Ohte S, Miyachi N, Kobayashi K, Sato N, et al. 2013. New dinapinone derivatives, potent inhibitors of triacylglycerol synthesis in mammalian cells, produced by Talaromyces pinophilus FKI-3864. J. Antibiot. (Tokyo) 66: 179-189.
    Pubmed CrossRef
  22. Kim J, Lee Y, Yu S. 1995. Sambutoxin-producing isolates of fusarium species and occurrence of sambutoxin in rotten potato tubers. Appl. Environ. Microbiol. 61: 3750-3751.
    Pubmed KoreaMed CrossRef
  23. Jayasinghe L, Abbas HK, Jacob MR, Herath WH, Nanayakkara NP. 2006. N-Methyl-4-hydroxy-2-pyridinone analogues from Fusarium oxysporum. J. Nat. Prod. 69: 439-442.
    Pubmed KoreaMed CrossRef
  24. Schmidt Y, Breit B. 2010. Direct assignment of the relative configuration in 1,3,n-methyl-branched carbon chains by 1H NMR spectroscopy. Org. Lett. 12: 2218-2221.
    Pubmed CrossRef
  25. Gupta GP, Massague J. 2006. Cancer metastasis: building a framework. Cell 127: 679-695.
    Pubmed CrossRef
  26. Hoshino S, Onaka H, Abe I. 2019. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria. J. Ind. Microbiol. Biotechnol. 46: 363-374.
    Pubmed CrossRef